Announcement

Collapse
No announcement yet.

NIH ACTIV Trial of blood thinners pauses enrollment of critically ill COVID-19 patients

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • NIH ACTIV Trial of blood thinners pauses enrollment of critically ill COVID-19 patients

    Tuesday, December 22, 2020

    Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients. Among critically ill COVID-19 patients requiring intensive care unit (ICU) support, therapeutic anticoagulation drugs did not reduce the need for organ support. Enrollment continues for moderately ill hospitalized COVID-19 patients in the trials.

    https://www.nih.gov/news-events/news...eE6rbM.twitter

Working...
X